Necrosis-Inducing High-Valent Oxo–Rhenium(V) Complexes with Potent Antitumor Activity: Synthesis, Aquation Chemistry, Cisplatin Cross-Resistance Profile, and Mechanism of Action
Inorganic Chemistry · 2023
DOI: 10.1021/acs.inorgchem.3c03110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2023. Verfasst von Shubhangi Das und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicinal Chemistry and Cell Biology, Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Navy N…. Hauptthemen laut MEDLINE: Rhenium, Coordination Complexes, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Department of Atomic Energy, Government of India, Science and Engineering Research Board, Tata Institute of Fundamental Research.
Abstract (Originalsprache)
Chemotherapy with the cytotoxic platinum (Pt) drugs cisplatin, carboplatin, and oxaliplatin is the mainstay of anticancer therapy in the clinic. The antitumor activity of Pt drugs originates from their ability to induce apoptosis via covalent adduct formation with nuclear DNA. While the phenomenal clinical success is highly encouraging, resistance and adverse toxic side effects limit the wider applicability of Pt drugs. To circumvent these limitations, we embarked on an effort to explore the antitumor potential of a new class of oxo-rhenium(V) complexes of the type [(N∧N)(EG)Re(O)Cl] (where EG = ethylene glycolate and N∧N = bipyridine, Bpy (1); phenanthroline, Phen (2); 3,4,7,8-tetramethyl-phenanthroline, Me4Phen (3)). Investigation of speciation chemistry in aqueous media revealed the formation of [(N∧N)Re(O)(OH)3] as the biologically active species. Complex 3 was found to be the most potent among the three, with IC50 values ranging from 0.1 to 0.4 μM against a panel of cancer cells, which is 5-70-fold lower when compared with cisplatin. The higher potency of 3 is attributed to its higher lipophilicity, which enhanced cellular uptake. Importantly, complex 3 efficiently overcomes cisplatin resistance in ovarian, lung, and prostate cancer cells. In addition to reporting the aquation chemistry and identifying the active species in aqueous media, we performed in-depth in vitro mechanistic studies, which revealed that complex 3 preferentially accumulates in mitochondria, depletes mitochondrial membrane potential, and upregulates intracellular reactive oxygen species (ROS), leading to ER stress-mediated necrosis-mediated cancer cell death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Medicinal Chemistry and Cell Biology, Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Navy Nagar, 400005 Mumbai, India.
- Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Navy Nagar, 400005 Mumbai, India.
ORCID-Profile: Pulkit Joshi, Malay Patra
Förderung
- Department of Atomic Energy, Government of India
- Science and Engineering Research Board
- Tata Institute of Fundamental Research
Zitieren
APA
Das, S., Joshi, P., & Patra, M. (2023). Necrosis-Inducing High-Valent Oxo–Rhenium(V) Complexes with Potent Antitumor Activity: Synthesis, Aquation Chemistry, Cisplatin Cross-Resistance Profile, and Mechanism of Action. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.3c03110
Vancouver
Das S, Joshi P, Patra M. Necrosis-Inducing High-Valent Oxo–Rhenium(V) Complexes with Potent Antitumor Activity: Synthesis, Aquation Chemistry, Cisplatin Cross-Resistance Profile, and Mechanism of Action. Inorganic Chemistry. 2023. doi:10.1021/acs.inorgchem.3c03110
BibTeX
@article{Das2023,
author = {Das, Shubhangi and Joshi, Pulkit and Patra, Malay},
title = {Necrosis-Inducing High-Valent Oxo–Rhenium(V) Complexes with Potent Antitumor Activity: Synthesis, Aquation Chemistry, Cisplatin Cross-Resistance Profile, and Mechanism of Action},
journal = {Inorganic Chemistry},
year = {2023},
doi = {10.1021/acs.inorgchem.3c03110}
}
EUVIMED